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Migrant Asian Indians have higher prevalence ratesof diabetes, premature coronary artery disease and
cardiovascular disease [CVD] mortality compared to the
host populations of these countries.1-3 Asian Indians
with diabetes also have higher mortality rates compared
to diabetic subjects of other ethnic groups.4  According
to recent reports, the prevalence rates of diabetes and
coronary artery disease in urban India are now similar
to migrant Asian Indians.5,6 Indeed, India already has
the largest number of people with diabetes in the world
and it is also predicted to lead in coronary artery disease
deaths in the next fifteen years.7 A recent report published
by the Indian Council of Medical Research (ICMR) in
2004, reported that in India, diabetes accounts for 1.09
lakh deaths/ year.8 However, there are very few
population-based studies on mortality rates in India and
virtually none comparing diabetic and non-diabetic
subjects. In this paper, we report on mortality data among
diabetic and non-diabetic subjects in a population-based
study in urban south India.
SUBJECTS AND METHODS
Baseline studies
The Chennai Urban Population Study [CUPS], an
ongoing epidemiological study in two residential
colonies in Chennai [formerly Madras, the largest city
in southern India] was started in 1996 and the baseline
study was completed in 1997. The methodological
details and several reports from CUPS have been
published.9,10 Briefly, all individuals ≥ 20 years of age
were invited to participate in a screening programme
for diabetes. The overall response rate was 90.2%.
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Abstract
Objective : The aim of this study was to determine the mortality rate in diabetic and non-diabetic subjects in
urban south India.
Methods : The Chennai Urban Population Study is an ongoing epidemiological study in Chennai [formerly
Madras, in south India]. All individuals ≥ 20 years of age living in two residential colonies in Chennai were
invited to participate in the study. Of the total 1399 eligible subjects, 1262 individuals responded [90.2%] at
baseline, and of these, 1140 individuals [90.3%] could be followed annually from 1997 to 2003-04. Mortality
rates and causes of death were the main outcome measures.
Results : The median follow up period was six years. The overall mortality rate was higher in diabetic
compared to non-diabetic subjects [18.9 vs.5.3 per 1000 person-years, p=0.004]. Mortality due to cardiovascular
[diabetic subjects, 52.9%; non-diabetic subjects, 24.2%,p=0.042] and renal causes[diabetic subjects, 23.5%;
non-diabetic subjects, 6.1%,p=0.072] was higher among diabetic subjects whereas mortality due to
gastrointestinal [12.1%], respiratory [9.1%], lifestyle related [6.1%] and unnatural causes [18.2%] were observed
only among non-diabetic subjects. Hazards ratio [HR] for all cause mortality for diabetes was 3.6, [95%
Confidence Interval [CI]: 2.02-6.53, p<0.001] and this remained significant even after adjusting for age [HR:1.9,
95% CI:1.04-3.45, p=0.038]. Light grade physical activity was associated with higher mortality rate [p=0.008],
but the significance disappeared when adjusted for age. Smoking was also associated with increased mortality.
Conclusions : In urban India, mortality rates are two fold higher in people with diabetes compared to non-
diabetic subjects. Cardiovascular and renal diseases are the commonest causes of death among diabetic
subjects. ©
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Anthropometric measures [weight, height, waist and
hip] and blood pressure were measured using standard
methods. A resting 12-lead electrocardiogram [ECG] was
carried out on 1175 subjects [response rate - 84%].
A fasting blood sample was taken for estimation of
glucose and lipids following which an oral glucose load
[75 gm] was administered to all individuals [excluding
known diabetic subjects]. All biochemical assays were
done using a Corning Express Plus Auto Analyser
[Corning, Medfield, MA, USA] using kits supplied by
Boehringer Mannheim [Mannheim, Germany].
Individuals were categorized based on a validated
physical activity [PA] questionnaire as having light,
moderate and heavy activity.10
Follow up data on mortality
From 1997, annual visits were made to every
household and details of all deaths were recorded. The
last visit was conducted between October 2003 and
August 2004.
Causes of death:  Unfortunately autopsies are usually
not performed in India except in some medico-legal
cases. We had to therefore make use of all available
sources of information to determine possible cause of
death. These included interview of family members and
wherever available, scrutiny of hospital records or the
deceased’s medical files, police records [where relevant]
and death certificates issued by the Corporation of
Chennai, the official body for registration of all deaths
in Chennai.
Causes of death were coded as: cardiovascular or CVD
[heart failure, myocardial infarction or stroke], renal,
gastrointestinal [gastrointestinal bleeding, cirrhosis or
hepatitis], respiratory [tuberculosis or chronic
obstructive pulmonary disease], cancer, lifestyle-related
[eg alcoholism], unnatural causes [suicides, accident],
others [deaths due to infection or aging] and the rest as
unknown causes.
Definitions
Type 2 diabetes was diagnosed based on WHO
consulting group criteria. Hypertension was diagnosed
using the JNC-VI criteria. Coronary artery disease [CAD]
was diagnosed based on a documented past history of
myocardial infarction or drug treatment for coronary
artery disease and/or Minnesota codes 1-1-1 to 1-1-7,
[Q wave changes] 4-1 to 4-2 [ST segment depression] or
5-1 to 5-3 [T wave abnormalities].6
Individuals were classified as non-smokers and
current smokers [habitual smokers regardless of quantity
smoked]. Alcohol intake was categorized as none, social
[occasional drinking] and regular [everyday intake
regardless of the quantity consumed].
STATISTICAL ANALYSIS
Mortality rates were calculated as number of deaths
per 1000 person-years of follow-up. Statistical analysis
was carried out using the SPSS PC Windows version
10.0 [Chicago, IL].  Students “t” test was used to compare
means and Chi Square or Fischer’s exact test to compare
proportions. Cox regression analysis was used to
determine the effect of various risk factors on mortality.
Survival curves were plotted by life-table analysis and
those of subjects with and without diabetes were
compared using Wilcoxon [Gehan] test.
RESULTS
Of the 1262 individuals who initially participated in
CUPS, 90 shifted their residence to another colony within
Chennai, 79 moved out of the state of Tamil Nadu and
23 left the country. We were able to obtain follow-up
data on all those who continued to reside in the same
colonies and 70 of the 90 who shifted their residence to
another colony within Chennai i.e. on a total of 1140
individuals [response rate: 1140 / 1262 – 90.3%] [Fig. 1].
The response rates among diabetic and non-diabetic
subjects were 94.1% and 89.8% respectively.
There were no significant differences in the baseline
characteristics of the responders [n = 1140] and non-
responders [n = 122] with respect to age: 43 ± 16 vs. 42 ±
16 years; gender: males: 44.5% vs. 41.0%; prevalence of
diabetes: 14.5% vs. 12.3% or prevalence of coronary
artery disease: 11.1% vs. 9.5%. However, the prevalence
of hypertension was higher among the responders
compared to non-responders [23.1% vs. 13.1%, p=0.012].
During the median follow up period of six-years, fifty
deaths [50/1140, 4.4%] were observed yielding an
overall all-cause mortality rate of 7.0 per 1,000 person-
years.
The percentage of deaths was significantly higher
among diabetic subjects [17/143, 11.9%] compared to
non-diabetic subjects [33/997, 3.3%, p <0.001] [Fig. 1].
This translates to an all-cause mortality of 18.9 per 1000
person years among diabetic subjects compared to 5.3
per 1000 person-years among non-diabetic subjects
[Table 1].
 Mortality due to CVD [52.9% vs. 24.2%,p=0.042] and
renal causes [23.5% vs. 6.1%,p=0.072] were higher
Fig. 1 : Flow-chart of the study protocol.
© JAPI • VOL. 54 • FEBRUARY 2006 www.japi.org 115
among diabetic, compared to non-diabetic subjects.
Deaths due to gastrointestinal [12.1%], respiratory [9.1%],
lifestyle related [6.1%] and unnatural causes [18.2%]
were observed only among non-diabetic subjects
[Table 1].
The mean age of death among diabetic subjects was
66 years compared to 54 years among non-diabetic
subjects [Table 2]. The mean age of subjects who died of
CVD causes was 65 ±11 years and 24% were less than
50 years old.
Among non-diabetic subjects who died, the proportion
of smokers was significantly higher [p<0.001]. Waist
circumference [p=0.004] and triglyceride levels [p<0.05]
were lower among the non-survivors compared to the
survivors. Among diabetic non-survivors, proportion of
hypertensives were significantly higher [p<0.05] and
they also had significantly higher systolic blood
pressure values [p=0.035]. However body mass index
[p=0.036], waist circumference [p=0.026] and
triglycerides were lower compared to the survivors.
None of the other parameters showed any significant
difference.
Mortality increased with increase in age intervals [age
≤ 50 years: 1.8%, 51-60 years: 5.0%, >60 years: 15.6%,
trend chi-square: 62.8, p<0.001]. When diabetic and non-
diabetic subjects were compared, at any given age
interval, diabetic subjects had increased death rates
compared to the non-diabetic subjects but the differences
did not reach statistical significance [diabetic vs non-
Table 1 : Causes of death in the population
Cause of death Total deaths Non-diabetic subjects Diabetic subjects
(n = 50) (n = 33) (n = 17)
Cardiovascular n (%) 17 (34) 8 (24.2) 9 (52.9)
Renal n (%) 6 (12) 2 (6.1) 4 (23.5)
Gastrointestinal mortality n (%) 4 (8) 4 (12.1) 0
Respiratory n (%) 3 (6) 3 (9.1) 0
Cancer n (%) 3 (6) 3 (9.1) 0
Unnatural causes n (%) 6 (12) 6 (18.2) 0
Lifestyle-related n (%) 2 (4) 2 (6.1) 0
Others
Age-related n (%) 2 (4) 1 (3.0) 1 (5.9)
Infections n (%) 2 (4) 1 (3.0) 1 (5.9)
Unknown n (%) 5 (10) 3 (9.1) 2 (11.8)
Mortality rate per 1000 person-years* 7.0 5.3 18.9 #
Numbers in parenthesis are percentages; * Mortality rates were calculated as the number of subjects died by person-years of follow-
up and are expressed as per 1000 person-years. # p=0.004 compared to non-diabetic subjects
Table 2 : Baseline demographic, clinical and biochemical  characteristics by diabetes status and all-cause mortality
Parameters Non-diabetic subjects Diabetic subjects
Survivors Non-survivors Survivors Non-survivors
(n = 964) (n = 33) (n = 126) (n = 17)
Age (yrs.)  41  ±  14  54  ±  16 ***  54  ±  11  66  ±  12 ***
Male n (%) 420 (43.6%) 16 (48.5%) 64 (50.8%) 7 (41.2%)
Systolic blood pressure (mm Hg)  119 ±  22  123 ±  20  131 ±  14  139 ±  17  *
Diastolic blood pressure (mm Hg)   77  ± 14   79  ±  12   84  ±  10   87  ±  11
Body mass index (kg/m2) 22.3 ± 4.4 21.0 ± 5.1 25.3 ± 4.0 23.1 ± 4.7 *
Waist circumference (cm)   76  ± 13   65  ±  19 **   87  ±  11   81  ±  11 *
Fasting plasma glucose (mg/dl)   76  ± 17   77  ± 15  153 ± 79 169  ± 131
Serum cholesterol (mg/dl) 167  ±  44 165  ±  40 199  ±  53 186  ±  66
Serum triglycerides (mg/dl)  111 ± 70   95  ± 32 *  172 ± 98 123  ± 55 *
Hypertension n (%) 185 (19.2%)  9 (27.3%) 57 (45.2%) 12 (70.6%) *
Coronary artery disease n (%)   86 (9.5%)  5 (16.7%) 21 (17.5%)  7  (43.8%)
Smoking n (%) 133 (13.8%) 10 (30.3%) **  9  (7.1%)  1 (5.9%)
Alcohol n (%) 237 (24.6%) 13 (39.4%) 29 (23.0%)  3 (17.6%)
* p < 0.05, ** p < 0.01, *** p < 0.001 compared to survivors
Fig.  2 : Age wise distribution of deceased in both diabetic and non-
diabetic subjects.
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diabetic, age ≤ 50 years : 2.0% vs. 1.7%, p=0.874, 51-60
years: 7.9% vs. 4.1%,p=0.342 >60 years: 23.2% vs.
12.1%,p=0.057] [Fig. 2].
Subjects who performed light grade activity had
higher death rates compared to subjects with heavy grade
activity  [6.5% vs. 2.7%, p=0.008].  The hazards ratio
[HR] for mortality among those with light grade activity
was 2.39 [95% confidence intervals [CI]: 1.05-5.40,
p=0.037] compared to heavy grade activity. However,
the significance disappeared when adjusted for age [HR:
1.41, 95% CI: 0. 61-3.27, p=0.418].
The number of pack-years of smoking was
significantly higher among the non-survivors [33.3 ±14.5]
compared to survivors [14.8 ± 12.8, p<0.001]. All-cause
mortality among smokers was 7.2% compared to 4.0%
among non-smokers. The association of smoking with
all-cause mortality remained significant even after age
adjustment [HR: 2.84, 95% CI: 1.44 – 5.62, p=0.003].
The survival curves were significantly different in
diabetic, compared to non-diabetic, subjects [Wilcoxon
[Gehan] test: p<0.001] [Fig. 3].
Hazard ratio for all-cause mortality was higher for
subjects with diabetes [HR: 3.6, 95% CI: 2.02-6.53,
p<0.001] compared to non-diabetic subjects and this
remained significant even after adjusting for age [HR:
1.9, 95% CI: 1.04-3.45, p=0.038].  The HR for diabetes for
mortality due to CVD was 7.8 [95% CI: 3.0 –20.2, p<0.001,
age adjusted: HR: 3.5, 95% CI: 1.3 – 9.1, p=0.012]. Diabetic
subjects also had very high risk for renal mortality
[unadjusted: HR: 14.3, 95% CI: 2.6 – 77.9, p<0.001.
adjusted for age: HR: 10.7, 95% CI: 1.7 – 67.4, p=0.012].
DISCUSSION
This is the first population-based study of mortality
rates in diabetic and non-diabetic subjects from India
and presents three major findings: first, mortality rates
in diabetic subjects are twice as high as in non-diabetic
subjects; second, cardiovascular and renal disease
contributed to majority of deaths among diabetic subjects
while lifestyle related, gastrointestinal and unnatural
deaths were more common among non-diabetic subjects
contributing to the lower age of death in the latter; finally,
physical activity and smoking showed an association
with all-cause mortality, but for the former, the
significance disappeared when adjusted for age.
Earlier studies from India on mortality do not provide
information on death rates in the general population.11,12
In this study, we report that the overall mortality rate in
the study population is 7.0 per 1000 person-years. The
mean age at death was 58 years, and 24% of CVD
mortality was seen among subjects less than 50 years of
age confirming earlier reports of premature deaths due
to CVD in Indians.2,3 The lower age at death of non-
diabetic subjects is perhaps fortuitous, probably due to
the small numbers and also due to gastrointestinal, life-
style related and unnatural causes. This scenario is likely
to change with rapidly increasing prevalence of diabetes
and control of communicable diseases in India.
Indeed, subjects with diabetes had two-fold higher
risk for mortality compared to non-diabetic subjects, even
after age adjustment and this corroborates earlier
studies.13-16 Survival rates were markedly lower among
diabetic subjects and this was mostly due to CVD. The
causes for increased cardiovascular deaths among
diabetic subjects are multiple and include elevated
glucose and blood pressure, dyslipidemia and
inflammation. Multiple interventions are therefore
needed to reduce cardiovascular risk in diabetic
subjects.17
The second commonest cause of death in diabetic
subjects was renal disease accounting for 23.5% of the
deaths, which is similar to figures reported in other
studies.18 However, in contrast to earlier studies from
India,11,12,19 mortality due to infections was found to be
less common. This might be due to the fact that earlier
studies were hospital-based and referral bias could
explain excess of deaths due to infections or may be due
to misclassification bias.
In the Aerobics Center Longitudinal Study (ACLS)
conducted among middle-aged men with type 2
diabetes, physical inactivity was an independent
predictor of all-cause mortality.20 The National Health
Interview Survey (NHIS), which examined the
relationship of walking and other physical activities to
all cause mortality among US adults with diabetes
reported that higher levels of physical activity were
associated with a lower incidence of all-cause mortality.21
Our finding demonstrates that physical inactivity was
associated with all-cause mortality. However, age
appears to be an effect modifier as it abolished the
relation of physical inactivity with mortality.
Surprisingly, the non-survivors had lower body mass
index. This may reflect inadequate control of diabetes,
resulting in weight loss. The lower triglyceride levels in
the non-survivors can be explained by the use of lipid
lowering drugs, as 16.7% of non-diabetic non-survivors
and 43.8% among diabetic non-survivors had coronary
Fig. 3 : Survival curves for diabetic and non-diabetic subjects
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artery disease at baseline and hence were on treatment
with lipid lowering drugs. Smoking was associated with
all-cause mortality and this is similar to results in other
populations.22
There are several limitations to this study. These
include availability of soft evidence of cause of death
due to improper filling of death certificates and
inaccuracy of verbal accounts given by relatives of the
deceased. Indeed, the cause of death was unknown in
some cases due to non-availability of medical records.
Moreover the cause of death recorded in death certificates
may be unreliable as diabetes is rarely recorded as a
cause of death.23 Finally, the number of deaths is quite
small as the original cohort itself consisted of only 1262
subjects. However, main strength of the study is that the
data collected is from the community. The other strengths
are that the response rate is very good, the data collected
has helped to reasonably identify the cause of death in
the population and this is the first paper from India to
report on mortality due to diabetes. The results of the
study can probably be extrapolated to most of urban
India, as the prevalence rates of diabetes and CVD are
fairly similar across most cities in India.20 However in
rural India, the prevalence of both diabetes and CVD is
less than half of that in urban areas and hence mortality
data is also likely to be quite different from that seen in
urban areas.
In conclusion, this study highlights that diabetic
subjects had higher mortality rates compared to non-
diabetic subjects. Cardiac disease and renal diseases
were the commonest cause for mortality in diabetic
subjects. Smoking and physical inactivity are associated
with all cause mortality.
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